Researchers developed and validated an AI model that simultaneously detects multiple genetic markers in colorectal cancer tissue slides.
Key Details
- 1Study led by EKFZ for Digital Health at TU Dresden analyzed nearly 2,000 digitized pathology slides across seven independent cohorts in Europe and the US.
- 2The AI 'multi-target transformer' model predicts a wide range of genetic alterations, including microsatellite instability and BRAF/RNF43 mutations, from routine histological sections.
- 3Model performance matched or exceeded single-target models for key biomarkers and revealed the ability to identify shared morphological patterns tied to multiple mutations.
- 4Findings published in The Lancet Digital Health, with plans to extend methods to other cancers.
- 5Collaboration involved multiple academic centers, highlighting interdisciplinary and international partnership.
Why It Matters
This work represents a substantial advance for digital pathology and AI-driven precision diagnostics, potentially enabling faster, more comprehensive, and scalable assessment of genetic biomarkers directly from standard tissue images. Faster and lower-cost pre-screening for key mutations could streamline patient selection for molecular testing and personalize colorectal cancer care.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
AI-Driven Handheld Endomicroscope Enhances Early Cancer Detection
Researchers develop PrecisionView, a handheld AI-powered endomicroscope for real-time, high-resolution cancer diagnostics.
•EurekAlert
AI Model Uses EKG and EHR Data to Predict Sudden Cardiac Arrest
Researchers have developed AI models that analyze EKG and EHR data to predict risk of sudden cardiac arrest in the general population.